Pharmaceutical composition for ophthalmic use

Details Pharmaceutical composition for ophthalmic use Pharmaceutical composition for ophthalmic use

A - Human Necessities

61

K

A61K 31/7016 (2006.01) A61K 9/06 (2006.01) A61K 9/08 (2006.01) A61K 31/198 (2006.01) A61K 31/401 (2006.01) A61K 31/405 (2006.01) A61K 31/4172 (2006.01) A61K 31/715 (2006.01) A61P 27/02 (2006.01) A61P 27/14 (2006.01)

Patent

CA 2355814

An ophthalmic pharmaceutical composition comprising trehalose as an effective ingredient and a pharmaceutically--acceptable carrier. The pharmaceutical composition is a safe, long-term continuously-administrable, therapeutic and/or prophylactic agent for the ophthalmologic clinical symptoms and signs in Sjögren syndrome.

L'invention porte sur une composition pharmaceutique pour utilisation ophtalmologique contenant du tréhalose comme ingrédient actif et un vecteur pharmaceutiquement acceptable. La composition pharmaceutique est sûre et thérapeutique. Elle peut être administrée à long terme de façon continue et constitue un agent prophylactique pour traiter les signes et les symptômes cliniques du syndrome de Sjögren.

Affiliated with

Also associated with

Rating

Pharmaceutical composition for ophthalmic use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for ophthalmic use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for ophthalmic use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1689624